Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Zou, Jun ^a   Huang, Xiao Xi ^a   Yin, Guang Wen ^a   Ding, Ye ^a   Liu, Xian Yong ^a   Wang, Heng ^b   Chen, Qi Jun ^c   Suo, Xun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TOXOPLASMA GONDII VACCINE; YELLOW FLUORESCENT PROTEIN; BACTERIAL PROTEIN; DRUG CARRIER; IMMUNOGLOBULIN G; LIVE VACCINE; PHOTOPROTEIN; PROTOZOAL VACCINE; RECOMBINANT PROTEIN; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; COCCIDIOSIS; CONTROLLED STUDY; EIMERIA TENELLA; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; RABBIT; T LYMPHOCYTE; TH1 CELL; TOXOPLASMA GONDII; ANIMAL; BLOOD; GENE VECTOR; GENETICS; IMMUNOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TOXOPLASMA;

ANIMALIA; GALLUS GALLUS; ORYCTOLAGUS CUNICULUS; TOXOPLASMA GONDII;

ANIMALS; BACTERIAL PROTEINS; CHICKENS; DRUG CARRIERS; GENETIC VECTORS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; LUMINESCENT PROTEINS; PROTOZOAN VACCINES; RABBITS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TOXOPLASMA; VACCINES, ATTENUATED;

EID: 80052028316     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-168     Document Type: Article

References (47)

1. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria. Charest H, Sedegah M, Yap GS, Gazzinelli RT, Caspar P, Hoffman SL, Sher A, J Immunol 2000 165 2084 2092 10925293 (Pubitemid 30643157)
2. Nonsegmented negative-strand viruses as vaccine vectors. Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL, J Virol 2006 80 10293 10306 10.1128/JVI.00919-06 17041210 (Pubitemid 44628877)
3. Salmonella typhi: from a human pathogen to a vaccine vector. Zhang XL, Jeza VT, Pan Q, Cell Mol Immunol 2008 5 91 97 10.1038/cmi.2008.11 18445338
4. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Konjufca V, Wanda SY, Jenkins MC, Curtiss R, Infect Immun 2006 74 6785 6796 10.1128/IAI.00851-06 16982843 (Pubitemid 44913153)
5. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. McMahon-Pratt D, Rodriguez D, Rodriguez JR, Zhang Y, Manson K, Bergman C, Rivas L, Rodriguez JF, Lohman KL, Ruddle NH, et al. Infect Immun 1993 61 3351 3359 8335366 (Pubitemid 23223426)
6. Vaccinia virus: a tool for research and vaccine development. Moss B, Science 1991 252 1662 1667 10.1126/science.2047875 2047875 (Pubitemid 21917083)
7. Vaccine Protocols. Gunilla B, Karlsson PL, Humana Press, Robinson AMJH, Cranage MP, 2
8. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, Walop W, Ellis CE, King A, Pediatr Infect Dis J 2005 24 538 541 10.1097/01.inf. 0000164769.22033.2c 15933565 (Pubitemid 40847528)
9. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Denkers EY, Gazzinelli RT, Clin Microbiol Rev 1998 11 569 588 9767056 (Pubitemid 28497562)
10. Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Abu-Madi MA, Al-Molawi N, Behnke JM, Parasit Vectors 2008 1 39 10.1186/1756-3305-1-39 18937857
11. Seroprevalence of Toxoplasma gondii infection in dairy goats in Shaanxi Province, Northwestern China. Zhao GH, Zhang MT, Lei LH, Shang CC, Cao DY, Tian TT, Li J, Xu JY, Yao YL, Chen DK, Zhu XQ, Parasit Vectors 4 47
12. Toxoplasma gondii infection and abdominal hernia: evidence of a new association. Alvarado-Esquivel C, Estrada-Martinez S, Parasit Vectors 4 112
13. Development of a vaccine for toxoplasmosis: current status. Bhopale GM, Microbes Infect 2003 5 457 462 10.1016/S1286-4579(03)00048-0 12738002 (Pubitemid 36549188)
14. Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. Wilkins MF, O'Connell E, Te Punga WA, N Z Vet J 1988 36 86 89 10.1080/00480169.1988.35489 16031449
15. A commercial vaccine for ovine toxoplasmosis. Buxton D, Innes EA, Parasitology 1995 110 Suppl 11 16 7784124
16. Toxoplasmosis in sheep - the last 20 years. Dubey JP, Vet Parasitol 2009 163 1 14 10.1016/j.vetpar.2009.02.026 19395175
17. Molecular genetic tools in Toxoplasma and Plasmodium: achievements and future needs. Meissner M, Breinich MS, Gilson PR, Crabb BS, Curr Opin Microbiol 2007 10 349 356 10.1016/j.mib.2007.07.006 17826309 (Pubitemid 47404957)
18. Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice. Ramirez JR, Gilchrist K, Robledo S, Sepulveda JC, Moll H, Soldati D, Berberich C, Vaccine 2001 20 455 461 10.1016/S0264-410X(01)00341-3 11672909 (Pubitemid 32973788)
19. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Denkers EY, Microbes Infect 1999 1 699 708 10.1016/S1286-4579(99)80071-9 10611747
20. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Choi I, Chung HK, Ramu S, Lee HN, Kim KE, Lee S, Yoo J, Choi D, Lee YS, Aguilar B, Hong YK, Blood
21. A novel polymer of tubulin forms the conoid of Toxoplasma gondii. Hu K, Roos DS, Murray JM, J Cell Biol 2002 156 1039 1050 10.1083/jcb.200112086 11901169 (Pubitemid 34839853)
22. Daughter cell assembly in the protozoan parasite Toxoplasma gondii. Hu K, Mann T, Striepen B, Beckers CJ, Roos DS, Murray JM, Mol Biol Cell 2002 13 593 606 10.1091/mbc.01-06-0309 11854415 (Pubitemid 34165086)
23. A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Medina-Bolivar F, Wright R, Funk V, Sentz D, Barroso L, Wilkins TD, Petri W Jr, Cramer CL, Vaccine 2003 21 997 1005 10.1016/S0264-410X(02)00551-0 12547614 (Pubitemid 36126436)
24. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Gubbels MJ, Li C, Striepen B, Antimicrob Agents Chemother 2003 47 309 316 10.1128/AAC.47.1.309-316.2003 12499207 (Pubitemid 36070380)
25. Transgenic Eimeria tenella Expressing Enhanced Yellow Fluorescent Protein (EYFP) as a Model Antigen Stimulated Host Immune Responses to the Heterogenous Protein-Targeted to Different Cellular Compartments. Xiaoxi Huang JZ, Xianyong Liu, Xun Suo
26. A guide to laboratory techniques used in the study and diagnosis of avian coccidiosis. Long PL, Millard BJ, Joyner LP, Norton CC, Folia Vet Lat 1976 6 201 217 1010500
27. Transient transfection of Eimeria tenella using yellow or red fluorescent protein as a marker. Hao L, Liu X, Zhou X, Li J, Suo X, Mol Biochem Parasitol 2007 153 213 215 10.1016/j.molbiopara.2007.02.005 17399806 (Pubitemid 46654244)
28. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Roos DS, Donald RG, Morrissette NS, Moulton AL, Methods Cell Biol 1994 45 27 63 7707991
29. Restriction enzyme-mediated integration elevates transformation frequency and enables co-transfection of Toxoplasma gondii. Black M, Seeber F, Soldati D, Kim K, Boothroyd JC, Mol Biochem Parasitol 1995 74 55 63 10.1016/0166-6851(95) 02483-2 8719245 (Pubitemid 26021035)
30. Transfection of Eimeria and Toxoplasma using heterologous regulatory sequences. Zou J, Liu X, Shi T, Huang X, Wang H, Hao L, Yin G, Suo X, Int J Parasitol 2009 39 1189 1193 10.1016/j.ijpara.2009.03.006 19379753
31. Intestinal immune responses to coccidiosis. Yun CH, Lillehoj HS, Lillehoj EP, Dev Comp Immunol 2000 24 303 324 10.1016/S0145-305X(99)00080-4 10717295 (Pubitemid 30136308)
32. Role of T lymphocytes and cytokines in coccidiosis. Lillehoj HS, Int J Parasitol 1998 28 1071 1081 10.1016/S0020-7519(98)00075-7 9724878 (Pubitemid 28364735)
33. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Shen H, Miller JF, Fan X, Kolwyck D, Ahmed R, Harty JT, Cell 1998 92 535 545 10.1016/S0092-8674(00)80946-0 9491894 (Pubitemid 28101116)
34. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Zhang G, Huang X, Boldbaatar D, Battur B, Battsetseg B, Zhang H, Yu L, Li Y, Luo Y, Cao S, et al. Vaccine 28 7243 7247
35. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects. Shirafuji H, Xuan X, Kimata I, Takashima Y, Fukumoto S, Otsuka H, Nagasawa H, Suzuki H, J Parasitol 2005 91 476 479 10.1645/GE-364R1 15986633 (Pubitemid 40756295)
36. Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. Nishikawa Y, Xuenan X, Makala L, Vielemeyer O, Joiner KA, Nagasawa H, Int J Parasitol 2003 33 1525 1535 10.1016/S0020-7519(03)00204-2 14572515 (Pubitemid 37324190)
37. Expression of Cpgp40/15 in Toxoplasma gondii: a surrogate system for the study of Cryptosporidium glycoprotein antigens. O'Connor RM, Kim K, Khan F, Ward HD, Infect Immun 2003 71 6027 6034 10.1128/IAI.71.10.6027-6034.2003 14500524 (Pubitemid 37205656)
38. Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. O'Connor RM, Wanyiri JW, Wojczyk BS, Kim K, Ward H, Mol Biochem Parasitol 2007 152 149 158 10.1016/j.molbiopara.2007.01.003 17275106
39. The Eimeria genome projects: a sequence of events. Shirley MW, Ivens A, Gruber A, Madeira AM, Wan KL, Dear PH, Tomley FM, Trends Parasitol 2004 20 199 201 10.1016/j.pt.2004.02.005 15105014 (Pubitemid 38510311)
40. ToxoDB: accessing the Toxoplasma gondii genome. Kissinger JC, Gajria B, Li L, Paulsen IT, Roos DS, Nucleic Acids Res 2003 31 234 236 10.1093/nar/gkg072 12519989 (Pubitemid 36150372)
41. Experimental toxoplasmosis in broiler chicks. Kaneto CN, Costa AJ, Paulillo AC, Moraes FR, Murakami TO, Meireles MV, Vet Parasitol 1997 69 203 210 10.1016/S0304-4017(96)01126-0 9195730 (Pubitemid 27283486)
42. Antigenemia and specific IgM and IgG antibody responses in rabbits infected with Toxoplasma gondii. Quan JH, Hassan HA, Cha GH, Shin DW, Lee YH, Korean J Parasitol 2009 47 409 412 10.3347/kjp.2009.47.4.409 19967092
43. Secretion of proteins into host cells by Apicomplexan parasites. Ravindran S, Boothroyd JC, Traffic 2008 9 647 656 10.1111/j.1600-0854.2008. 00723.x 18266908 (Pubitemid 351494297)
44. Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. Frickel EM, Sahoo N, Hopp J, Gubbels MJ, Craver MP, Knoll LJ, Ploegh HL, Grotenbreg GM, J Infect Dis 2008 198 1625 1633 10.1086/593019 18922097
45. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Blanchard N, Gonzalez F, Schaeffer M, Joncker NT, Cheng T, Shastri AJ, Robey EA, Shastri N, Nat Immunol 2008 9 937 944 10.1038/ni.1629 18587399
46. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. Kwok LY, Lutjen S, Soltek S, Soldati D, Busch D, Deckert M, Schluter D, J Immunol 2003 170 1949 1957 12574363 (Pubitemid 36197414)
47. Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens. Wallny HJ, Avila D, Hunt LG, Powell TJ, Riegert P, Salomonsen J, Skjodt K, Vainio O, Vilbois F, Wiles MV, Kaufman J, Proc Natl Acad Sci USA 2006 103 1434 1439 10.1073/pnas.0507386103 16432226 (Pubitemid 43191183)